These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22083630)

  • 1. A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms.
    Wang Y; Armenante PM
    J Pharm Sci; 2012 Feb; 101(2):746-60. PubMed ID: 22083630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing.
    Bai G; Armenante PM
    J Pharm Sci; 2009 Apr; 98(4):1511-31. PubMed ID: 18781589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2.
    Zhang Y; Bredael G; Armenante PM
    J Pharm Sci; 2013 Aug; 102(8):2718-29. PubMed ID: 23861178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of variability in dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Smith AP; Doub WH; Westenberger BJ
    J Pharm Sci; 2007 Jul; 96(7):1794-801. PubMed ID: 17252609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cause of high variability in drug dissolution testing and its impact on setting tolerances.
    Qureshi SA; Shabnam J
    Eur J Pharm Sci; 2001 Jan; 12(3):271-6. PubMed ID: 11113646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A better dissolution method for ranitidine tablets USP.
    Cappola ML
    Pharm Dev Technol; 2001; 6(1):11-7. PubMed ID: 11247270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
    Deng G; Ashley AJ; Brown WE; Eaton JW; Hauck WW; Kikwai LC; Liddell MR; Manning RG; Munoz JM; Nithyanandan P; Glasgow MJ; Stippler E; Wahab SZ; Williams RL
    Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrodynamic investigation of USP dissolution test apparatus II.
    Bai G; Armenante PM; Plank RV; Gentzler M; Ford K; Harmon P
    J Pharm Sci; 2007 Sep; 96(9):2327-49. PubMed ID: 17573698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Evaluation of Dissolution Performance in a USP 2 Setup and Alternative Stirrers and Vessel Designs: A Systematic Computational Investigation.
    Salehi N; Al-Gousous J; Hens B; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2024 May; 21(5):2406-2414. PubMed ID: 38639477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical modeling of variables involved in dissolution testing.
    Gao Z
    J Pharm Sci; 2011 Nov; 100(11):4934-42. PubMed ID: 21702052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vibration effects on dissolution tests with USP apparatuses 1 and 2.
    Gao Z; Moore TW; Doub WH
    J Pharm Sci; 2008 Aug; 97(8):3335-43. PubMed ID: 18000813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of vibration and agitation speed on dissolution of USP prednisone tablets RS and various IR tablet formulations.
    Seeger N; Lange S; Klein S
    AAPS PharmSciTech; 2015 Aug; 16(4):759-66. PubMed ID: 26104919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved drug dissolution and product characterization using a crescent-shaped spindle.
    Qureshi SA
    J Pharm Pharmacol; 2004 Sep; 56(9):1135-41. PubMed ID: 15324482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Media Flow and Tablet Position as Factors of How Air Bubbles Affect Dissolution of Disintegrating and Non-disintegrating Tablets Using a USP 4 Flow-Through Cell Apparatus.
    Yoshida H; Teruya K; Abe Y; Furuishi T; Fukuzawa K; Yonemochi E; Izutsu KI
    AAPS PharmSciTech; 2021 Aug; 22(7):227. PubMed ID: 34431011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
    Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W
    Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Velocity distribution and shear rate variability resulting from changes in the impeller location in the USP dissolution testing apparatus II.
    Bai G; Armenante PM
    Pharm Res; 2008 Feb; 25(2):320-36. PubMed ID: 18040760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D hydrodynamics and shear rates' variability in the United States Pharmacopeia Paddle Dissolution Apparatus.
    Ameur H; Bouzit M
    Int J Pharm; 2013 Aug; 452(1-2):42-51. PubMed ID: 23680733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The random vibration effects on dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Buhse LF; Doub WH
    J Pharm Sci; 2009 Jan; 98(1):297-306. PubMed ID: 18399543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.
    Qureshi SA; McGilveray IJ
    Eur J Pharm Sci; 1999 Feb; 7(3):249-58. PubMed ID: 9845813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the Influence of Tablet Location Inside Dissolution Test Apparatus on Polymer Erosion and Drug Release of a Surface-Erodible Sustained-Release Tablet Using Computational Simulation Methods.
    Lou H; Hageman MJ
    AAPS PharmSciTech; 2021 Mar; 22(3):99. PubMed ID: 33709248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.